Anbio Biotechnology (NASDAQ:NNNN) Trading 6.8% Higher – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN) shares shot up 6.8% during mid-day trading on Wednesday . The stock traded as high as $12.68 and last traded at $12.50. Approximately 3,397 shares traded hands during trading, a decline of 92% from the average daily volume of 44,826 shares. The stock had previously closed at $11.70.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold”.

Anbio Biotechnology Stock Down 0.4%

The business’s fifty day simple moving average is $22.82.

Anbio Biotechnology (NASDAQ:NNNN) last issued its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.